MedPath

Dietary Antioxidants and Chronic Diseases-The Swedish National March Cohort

Completed
Conditions
Osteoarthritis
Myocardial Infarction
Diet
Registration Number
NCT03350568
Lead Sponsor
Karolinska Institutet
Brief Summary

Dietary antioxidants might protect from the development of chronic diseases by reducing levels of oxidative stress. The investigators therefore investigated the effect of dietary Non Enzymatic Antioxidant Capacity, which measures interactions between antioxidants in the whole diet, on the risk of 1) myocardial infarction and 2) osteoarthritis.

Detailed Description

Aim: Among an initial sample of 43,880 men and women who participated in the Swedish National March Cohort in 1997 the investigators aimed to investigate the effect of dietary Non Enzymatic Antioxidant Capacity (NEAC), assessed by a validated food frequency questionnaire at baseline, on the risk of 1) myocardial infarction and 2) osteoarthritis.

Identification of cases: Incident cases of myocardial infarction (ICD-10 code I21) and osteoarthritis (ICD-10 M15-19) were identified through exact linkages to the Swedish registries of population, migration, death, cancer, and inpatient care, using the national registration numbers as identifiers.

Main methods: The investigators fitted Cox proportional hazards regression models with age as underlying time scale to estimate hazard ratios (HR) with 95% confidence intervals (95% CI) for each outcome of interest at different levels of dietary NEAC. The investigators fitted multiple imputation models based on chained equations to address missingness of confounder variables.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
43880
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
OsteoarthritisOctober 1, 1997-December 31, 2010

Based on ICD-10 M15-19

Myocardial InfarctionOctober 1, 1997-December 31, 2010

Based on ICD-10 I21

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Karolinska Institutet

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath